Soergel David

Chief Medical Officer at MDGL; Sr. VP,Clinical Dev. & CMO at TREVENA INC

Sold, on record
$1.2M
Dollars the filings state
Form 4 sales
3
Latest Jun 1, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • MDGLMADRIGAL PHARMACEUTICALS, INC.Chief Medical Officer
  • TREVENA INCSr. VP,Clinical Dev. & CMO

Sales by reason

1
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale TREVENA INCUnusual
    Dec 10, 2015 2015

    Sold 27,217 shares at $10.55 ($287k)

    Soergel David, Sr. VP,Clinical Dev. & CMO

    Sold 94% of holdings ($306k position)1,750 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale MDGLNo plan
    May 18, 2026 +3812 days

    Sold 844 shares at $515.90 ($435k)

    Soergel David, Chief Medical Officer

    No 10b5-1 planSold 7.1% of holdings ($6.1M position)11,075 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale MDGLRoutine
    Jun 1, 2026 +14 days

    Sold 1,042 shares at $495.74 ($517k)

    Soergel David, Chief Medical Officer

    10b5-1 planSold 9.4% of holdings ($5.5M position)10,033 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Soergel David
Source
Jun 1, 2026Jun 1, 2026MDGLChief Medical OfficerForm 4 sale1,042$517k9.4%RoutineSEC
May 18, 2026May 18, 2026MDGLChief Medical OfficerForm 4 sale844$435k7.1%No planSEC
Dec 10, 2015Dec 11, 2015TREVENA INCSr. VP,Clinical Dev. & CMOForm 4 sale27,217$287k94.0%UnusualSEC